Clinical and mycological implications of cryptococcal meningitis in Iran

Bahareh Bashardoust1,2, Ilad Alavi Darazam3,4,5, Roshanak Daie Ghazvini1

  • 1Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Heliyon
|November 1, 2023
PubMed

Insights

Cryptococcal meningitis (CM) is a severe infection. This study in Iran found CM in 2.6% of meningitis cases, with high mortality and specific antifungal resistance patterns.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Epidemiology

Background:

  • Cryptococcal meningitis (CM) is a severe central nervous system infection, affecting both immunocompromised and immunocompetent individuals.
  • Limited data exists on the clinical and epidemiological profile of CM in Iran, necessitating local research.

Purpose of the Study:

  • To investigate the clinical and epidemiological characteristics of cryptococcal meningitis in Iran.
  • To analyze the diagnostic methods, causative species, and antifungal susceptibility profiles of Cryptococcus isolates in Iranian patients.

Main Methods:

  • A multicenter study evaluated 272 patients with subacute or chronic meningitis across 15 Iranian hospitals.
  • Diagnosis involved microscopic examination, culture, latex agglutination, lateral flow assay, and multiplex PCR on cerebrospinal fluid (CSF).
  • Molecular identification and in vitro antifungal susceptibility testing were performed on isolated Cryptococcus species.

Main Results:

  • Seven cases (2.6%) of CM were diagnosed, predominantly in males (86%) with a median age of 36.
  • Headache (100%) and nausea/vomiting (71.4%) were the most common neurological signs.
  • Isolates were identified as Cryptococcus neoformans (86%) and Cryptococcus gattii (14%). High mortality (86%) was observed.

Conclusions:

  • CM is a rare but severe condition in Iran, characterized by specific clinical presentations and high mortality.
  • Observed antifungal resistance to itraconazole and amphotericin B highlights potential treatment challenges.
  • This study provides crucial data for understanding CM in Iran and low-income countries, informing future research and clinical management.